An earlier study found significant overexpression of FSCN1 in human epithelial tumors (lung, cervical, ovarian, esophageal, pancreatic, gastric, hepatocellular, colorectal, breast, nasopharyngeal, and laryngeal carcinomas) in comparison with their corresponding normal tissues, leading to the conclusion that overexpression of FSCN1 correlates with tumor occurrence and progression [50]. This evidence concerns the gene FSCN1 and laryngeal carcinoma.